Literature DB >> 3225610

Complete visual inversion in vertebrobasilar ischaemic disease.

M F Mehler.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3225610      PMCID： PMC1033037          DOI： 10.1136/jnnp.51.9.1236

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Acute "upside down" reversal of vision in transient vertebrobasilar ischemia.

Authors:  I Steiner; R Shahin; E Melamed
Journal:  Neurology       Date:  1987-10       Impact factor: 9.910

2.  Wallenberg's syndrome. I. General symptomatology, with special reference to visual disturbances and imbalance.

Authors:  G Hörnsten
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

3.  Lateropulsion and imbalance in Wallenberg's syndrome.

Authors:  K Bjerver; B P Silfverskiöld
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

4.  The judgement of the visual vertical and horizontal with peripheral and central vestibular lesions.

Authors:  G Friedmann
Journal:  Brain       Date:  1970       Impact factor: 13.501

5.  Constant error of visual egocentric orientation in patients with acute vestibular disorder.

Authors:  G Hörnsten
Journal:  Brain       Date:  1979-12       Impact factor: 13.501
  5 in total
  3 in total

1.  Acute "upside-down" visual inversion in a patient with multiple sclerosis.

Authors:  Orhan Deniz; Hava Donmez Keklikoglu; Gonul Vural; Sadiye Temel; Fatma Aysen Dilbaz
Journal:  Neurol Sci       Date:  2011-09-25       Impact factor: 3.307

2.  Acute upside down reversal of vision in vertebrobasilar ischaemia.

Authors:  A Stracciari; M Guarino; G Ciucci; P Pazzaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

Review 3.  Clinical and imaging features of the room tilt illusion.

Authors:  F Sierra-Hidalgo; E de Pablo-Fernández; A Herrero-San Martín; E Correas-Callero; J Herreros-Rodríguez; J P Romero-Muñoz; L Martín-Gil
Journal:  J Neurol       Date:  2012-05-16       Impact factor: 4.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.